vs

Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and WSFS FINANCIAL CORP (WSFS). Click either name above to swap in a different company.

WSFS FINANCIAL CORP is the larger business by last-quarter revenue ($275.3M vs $151.7M, roughly 1.8× Nutex Health, Inc.). WSFS FINANCIAL CORP runs the higher net margin — 31.5% vs 7.8%, a 23.7% gap on every dollar of revenue. On growth, WSFS FINANCIAL CORP posted the faster year-over-year revenue change (7.5% vs -41.1%). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 1.7%).

Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.

WSFS Financial Corporation is a financial services company. Its primary subsidiary, WSFS Bank, a federal savings bank, is the largest and longest-standing locally managed bank and wealth management franchise headquartered in Delaware and the Greater Delaware Valley. WSFS operates from 115 offices, 88 of which are banking offices, located in Pennsylvania (57), Delaware (39), New Jersey (14), Florida (2), Virginia (1), and Nevada (1) and provides comprehensive financial services including comme...

NUTX vs WSFS — Head-to-Head

Bigger by revenue
WSFS
WSFS
1.8× larger
WSFS
$275.3M
$151.7M
NUTX
Growing faster (revenue YoY)
WSFS
WSFS
+48.6% gap
WSFS
7.5%
-41.1%
NUTX
Higher net margin
WSFS
WSFS
23.7% more per $
WSFS
31.5%
7.8%
NUTX
Faster 2-yr revenue CAGR
NUTX
NUTX
Annualised
NUTX
50.0%
1.7%
WSFS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
NUTX
NUTX
WSFS
WSFS
Revenue
$151.7M
$275.3M
Net Profit
$11.8M
$86.8M
Gross Margin
30.4%
Operating Margin
20.4%
Net Margin
7.8%
31.5%
Revenue YoY
-41.1%
7.5%
Net Profit YoY
-80.8%
31.7%
EPS (diluted)
$2.34
$1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NUTX
NUTX
WSFS
WSFS
Q1 26
$275.3M
Q4 25
$151.7M
$271.9M
Q3 25
$267.8M
$270.5M
Q2 25
$244.0M
$267.5M
Q1 25
$211.8M
$256.1M
Q4 24
$257.6M
$261.5M
Q3 24
$78.8M
$267.7M
Q2 24
$76.1M
$266.0M
Net Profit
NUTX
NUTX
WSFS
WSFS
Q1 26
$86.8M
Q4 25
$11.8M
$72.7M
Q3 25
$55.4M
$76.4M
Q2 25
$-17.7M
$72.3M
Q1 25
$21.2M
$65.9M
Q4 24
$61.6M
$64.2M
Q3 24
$-8.8M
$64.4M
Q2 24
$-364.0K
$69.3M
Gross Margin
NUTX
NUTX
WSFS
WSFS
Q1 26
Q4 25
30.4%
Q3 25
57.8%
Q2 25
51.2%
Q1 25
55.9%
Q4 24
55.0%
Q3 24
27.8%
Q2 24
29.7%
Operating Margin
NUTX
NUTX
WSFS
WSFS
Q1 26
Q4 25
20.4%
35.8%
Q3 25
48.7%
37.3%
Q2 25
13.8%
35.7%
Q1 25
38.1%
34.0%
Q4 24
44.4%
32.3%
Q3 24
12.3%
31.9%
Q2 24
7.0%
34.0%
Net Margin
NUTX
NUTX
WSFS
WSFS
Q1 26
31.5%
Q4 25
7.8%
26.7%
Q3 25
20.7%
28.3%
Q2 25
-7.3%
27.0%
Q1 25
10.0%
25.7%
Q4 24
23.9%
24.6%
Q3 24
-11.2%
24.1%
Q2 24
-0.5%
26.0%
EPS (diluted)
NUTX
NUTX
WSFS
WSFS
Q1 26
$1.64
Q4 25
$2.34
$1.33
Q3 25
$7.76
$1.37
Q2 25
$-2.95
$1.27
Q1 25
$3.33
$1.12
Q4 24
$11.56
$1.08
Q3 24
$-1.72
$1.08
Q2 24
$-0.07
$1.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NUTX
NUTX
WSFS
WSFS
Cash + ST InvestmentsLiquidity on hand
$185.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$329.4M
$2.7B
Total Assets
$918.5M
$22.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NUTX
NUTX
WSFS
WSFS
Q1 26
Q4 25
$185.6M
$1.7B
Q3 25
$166.0M
Q2 25
$96.7M
Q1 25
$84.7M
Q4 24
$40.6M
$1.2B
Q3 24
$46.9M
Q2 24
$40.8M
Stockholders' Equity
NUTX
NUTX
WSFS
WSFS
Q1 26
$2.7B
Q4 25
$329.4M
$2.7B
Q3 25
$317.2M
$2.8B
Q2 25
$235.3M
$2.7B
Q1 25
$176.9M
$2.7B
Q4 24
$132.4M
$2.6B
Q3 24
$60.4M
$2.7B
Q2 24
$62.7M
$2.5B
Total Assets
NUTX
NUTX
WSFS
WSFS
Q1 26
$22.1B
Q4 25
$918.5M
$21.3B
Q3 25
$964.5M
$20.8B
Q2 25
$841.0M
$20.8B
Q1 25
$761.9M
$20.5B
Q4 24
$655.3M
$20.8B
Q3 24
$438.5M
$20.9B
Q2 24
$422.4M
$20.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NUTX
NUTX
WSFS
WSFS
Operating Cash FlowLast quarter
$70.4M
Free Cash FlowOCF − Capex
$69.0M
FCF MarginFCF / Revenue
45.5%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
5.95×
TTM Free Cash FlowTrailing 4 quarters
$245.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NUTX
NUTX
WSFS
WSFS
Q1 26
Q4 25
$70.4M
$220.0M
Q3 25
$99.5M
$121.5M
Q2 25
$27.3M
$37.2M
Q1 25
$51.0M
$8.7M
Q4 24
$54.0K
$219.9M
Q3 24
$6.8M
$3.1M
Q2 24
$13.3M
$44.8M
Free Cash Flow
NUTX
NUTX
WSFS
WSFS
Q1 26
Q4 25
$69.0M
$213.6M
Q3 25
$99.2M
$120.3M
Q2 25
$26.5M
$35.2M
Q1 25
$50.9M
$6.3M
Q4 24
$-341.0K
$205.6M
Q3 24
$6.2M
$-489.0K
Q2 24
$12.7M
$42.1M
FCF Margin
NUTX
NUTX
WSFS
WSFS
Q1 26
Q4 25
45.5%
78.6%
Q3 25
37.0%
44.5%
Q2 25
10.9%
13.2%
Q1 25
24.0%
2.5%
Q4 24
-0.1%
78.6%
Q3 24
7.8%
-0.2%
Q2 24
16.7%
15.8%
Capex Intensity
NUTX
NUTX
WSFS
WSFS
Q1 26
Q4 25
0.9%
2.3%
Q3 25
0.1%
0.5%
Q2 25
0.3%
0.7%
Q1 25
0.0%
0.9%
Q4 24
0.2%
5.5%
Q3 24
0.8%
1.4%
Q2 24
0.7%
1.0%
Cash Conversion
NUTX
NUTX
WSFS
WSFS
Q1 26
Q4 25
5.95×
3.03×
Q3 25
1.80×
1.59×
Q2 25
0.51×
Q1 25
2.40×
0.13×
Q4 24
0.00×
3.43×
Q3 24
0.05×
Q2 24
0.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NUTX
NUTX

Hospital Division$143.7M95%
Population Health Management Division$8.0M5%

WSFS
WSFS

Segment breakdown not available.

Related Comparisons